Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease.

Ramirez-Montagut T, Chow A, Kochman AA, Smith OM, Suh D, Sindhi H, Lu S, Borsotti C, Grubin J, Patel N, Terwey TH, Kim TD, Heller G, Murphy GF, Liu C, Alpdogan O, van den Brink MR.

J Immunol. 2007 Aug 1;179(3):1669-80.

2.
3.

Reconstructing immunity after allogeneic transplantation.

Giver CR, Li JM, Hossain MS, Lonial S, Waller EK.

Immunol Res. 2004;29(1-3):269-82. Review.

PMID:
15181288
4.

Cytokines in graft-versus-host disease and the graft-versus-leukemia reaction.

Deeg HJ.

Int J Hematol. 2001 Jul;74(1):26-32. Review.

PMID:
11530801
5.

Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.

Verneris MR, Baker J, Edinger M, Negrin RS.

J Clin Immunol. 2002 May;22(3):131-6. Review.

PMID:
12078854
6.

Tumor necrosis factor and immunopathology.

Piguet PF, Grau GE, Vassalli P.

Immunol Res. 1991;10(2):122-40. Review. No abstract available.

PMID:
1717618

Supplemental Content

Support Center